Clinical Trials Logo
  1. Home
  2. Dialysis
  3. NCT05305781
  4. Details
NCT05305781 Clinical Trial

Study of the Determinants of Emergency Dialysis in Reunion Island

Dialysis Clinical Trial

— PEPER  

Official title:
Prevalence and Epidemiology of Extra Renal Replacement Therapy

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05305781
Other study ID # 2021/CHU/24
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date March 1, 2022
Est. completion date August 2023

Study information
Verified date March 2022
Source Centre Hospitalier Universitaire de la Réunion
Contact Arnaud LE FLECHER, MD
Phone 0262 90 55 50
Email arnaud.leflecher@chu-reunion.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Among patients followed by nephrologists, the frequency of emergency dialysis starts' and their social and clinical determinants are not well known, especially in Reunion Island. In this context, we aim to study and understand the determinants of emergency dialysis initiation. For Reunion Island, the data remain very fragmented.

Recruitment information / eligibility
Status Recruiting
Enrollment 200
Est. completion date August 2023
Est. primary completion date April 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adult patient =18 years - Starting dialysis in a dialysis centre in Réunion Island - Having expressed their non-opposition or Emergency inclusion (non-opposition collected afterwards) Exclusion Criteria: - Under legal protection (safeguard of justice, guardianship) - Unable to answer questionnaires

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Réunion CHU de la Réunion Saint-Denis

Sponsors (1)
Lead Sponsor Collaborator
Centre Hospitalier Universitaire de la Réunion

Country where clinical trial is conducted

Réunion, 

Outcome
Type Measure Description Time frame Safety issue
Primary Characteristics of emergency analysis Incidence rate of emergency dialysis 24 hours
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05031013 - Trace Elements Concentration in Dialysis
Not yet recruiting NCT03090828 - Economic Evaluation of an Education Platform for Patients With End-stage Renal Disease N/A
Completed NCT01685372 - Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults Phase 2
Active, not recruiting NCT01394770 - Aliskiren or Amlodipine in Hypertensive Hemodialysed Patients Phase 4
Completed NCT00506441 - A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia Phase 3
Completed NCT00537979 - Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on Dialysis Phase 4
Completed NCT05415969 - CKD-aP Among Adults on Dialysis in Switzerland
Recruiting NCT04024007 - Determination of Citrate Clearance Used in Regional Anticoagulation of Continuous Venous Hemofiltration Circuits
Completed NCT03772171 - Estimate for Dietary Intakes and Hemodialysis Patients
Recruiting NCT02586402 - Safety & Efficacy of Pegolsihematide for Treatment of Anemia in Participants on Dialysis Phase 2
Active, not recruiting NCT01693263 - Outcome of BCF Access in Hemodialysis Patients
Completed NCT01421771 - Blood Pressure in Dialysis Patients N/A
Active, not recruiting NCT01065389 - Resistance Training in Intradialysis Patients Phase 2
Completed NCT00544492 - Study of Pain, Anxiety and Complications Related to Cannulation of Arteriovenous (AV) Fistula in Chronic Hemodialysis Patients Phase 4
Completed NCT03910426 - Prognostic Determinants of Survival and Quality of Life in Prevalent End-stage Kidney Disease Patients
Completed NCT04565522 - Transmission of COVID-19 Virus Among Patients and Staff in Dialysis Centers
Completed NCT04667741 - Post-dialysis Recovery Time and Affecting Factors Between Turkey and Portugal
Completed NCT04655989 - A Study to Demonstrate the Safety and Effectiveness of the NIKKISO DBB-EXA ES Hemodialysis Delivery System N/A
Completed NCT05125848 - Clinical Evaluation of the CM-1500 During Hemodialysis N/A
Completed NCT04633915 - Antibody Response in Hemodialysis and Non-dialysis Patients Diagnosed With COVID-19.